Amarantus Bioscience
Advanced search
Log in
Press Room
Releases
Multimedia
About
Amarantus BioSciences’ CEO Gerald Commissiong to Appear on the Big Biz Radio Show
3/16/2012 10:03 AM EST
Sunnyvale, CA –Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing MANF, a first-in-class disease–modifying therapeutic protein, today announced the company will be a featured guest on The Big Biz Radio Show on Monday, March 19, 2012 at 1:20 PM EDT. The live broadcast can be accessed via the show’s website: http://bigbizshow.com/media/ . Amarantus’ previous four appearances on the Big Biz Show and other CEO interviews are available for viewing online at http://www.amarantus.com/investor-relations/videos.html .
The Big Biz Show is a nationwide radio broadcast featuring commentators Bob Sullivan and Russ Nailz who discuss topics including current events, business trends, investment opportunities, innovations in headline making industries, and hot stock picks.
About Amarantus BioSciences, Inc.
Amarantus BioSciences, Inc. is a development-stage biotechnology company founded in January 2008. The Company has a focus on developing certain biologics and...
Amarantus BioSciences Releases New Video Interview with President and CEO Gerald Commissiong
1/6/2012 9:00 AM EST
Sunnyvale, CA, Jan. 6. 2012--Amarantus BioSciences Inc. (OTCBB: AMBS) is a biopharmaceutical company that has discovered a revolutionary therapeutic...
New Webcast Interview with President and CEO Gerald Commissiong (OTCBB: AMBS) Now Available at TheGreenBaron.com
11/29/2011 6:00 AM EST
SUNNYVALE, CA – November 29, 2011 – Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing MANF, a first-in-class disease–modifying therapeutic protein,...
Amarantus Bioscience, a Promising Biotech Company in Development
11/14/2011 10:48 AM EST
Miami, FL - Founded in California in 2008, Amarantus Biosciences, Inc. (OTCBB: AMBS) is now poised to take the biotech world by storm with their...
SEE ALL NEWS
Amarantus Bioscience
RSS
Subscribe by Email
View more
Tweet